An endoscopic treatment strategy for superficial tumors in patients with ulcerative colitis
Authors:
- Masafumi NishioMNMasafumi Nishio
- Kingo HirasawaKHKingo Hirasawa
- Yuichiro OzekiYOYuichiro Ozeki
- Atsushi SawadaASAtsushi Sawada
- Ryosuke IkedaRIRyosuke Ikeda
- Takehide FukuchiTFTakehide Fukuchi
- Ryosuke KobayashiRKRyosuke Kobayashi
- Makomo MakazuMMMakomo Makazu
- Chiko SatoCSChiko Sato
- Reiko KunisakiRKReiko Kunisaki
- Shin MaedaSMShin Maeda
- 4 August 2020
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 36 (2) , 498-506
Abstract
Background and Aim: Endoscopic resection is feasible for superficial tumors in patients with ulcerative colitis; however, endoscopic resection options have not been evaluated comprehensively. We evaluated the efficacy and safety of endoscopic submucosal dissection and endoscopic mucosal resection, and decision making regarding endoscopic resection options for patients with ulcerative colitis.Methods: Endoscopically treated tumors from patients with ulcerative colitis were analyzed retrospectively. We evaluated en bloc and R0 resection, adverse events, local tumor recurrence, and metachronous lesion occurrence rates.Results: We examined 102 tumors (mean size, 12 mm; non‐polypoid, 55 tumors) from 74 patients with ulcerative colitis, of whom, 39 and 63 underwent endoscopic submucosal dissection and endoscopic mucosal resection, respectively. The R0 resection rate was significantly higher for endoscopic submucosal dissection (97%) than for endoscopic mucosal resection (80%) (P = 0.0015). For 11–20‐mm tumors, the R0 resection rate was significantly higher for endoscopic submucosal dissection (94%) than for endoscopic mucosal resection (55%) (P = 0.0027); the endoscopic submucosal dissection and endoscopic mucosal resection R0 rates did not differ for ≤ 10‐mm tumors. The non‐polypoid tumor R0 resection rates were significantly higher for endoscopic submucosal dissection (100%) than for endoscopic mucosal resection (65%) (P < 0.001) and did not differ regarding the polypoid tumor R0 resection rates (75% vs 86%, P = 0.49). Four patients experienced intraoperative perforation during endoscopic submucosal dissection. No local recurrences occurred. Metachronous high‐grade dysplasia occurred in three patients during surveillance.Conclusions: In patients with ulcerative colitis, endoscopic submucosal dissection is suitable for ≥ 11‐mm and non‐polypoid tumors, whereas endoscopic mucosal resection is acceptable for ≤ 10‐mm tumors.Keywords
This publication has 31 references indexed in Scilit:
- The role of colorectal endoscopic submucosal dissection in patients with ulcerative colitisGastrointestinal Endoscopy, 2018
- Endoscopic submucosal dissection of colitis-related dysplasiaEndoscopy, 2017
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch DisordersJournal of Crohn's and Colitis, 2017
- Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) GuidelineEndoscopy, 2015
- SCENIC International Consensus Statement on Surveillance and Management of Dysplasia in Inflammatory Bowel DiseaseGastroenterology, 2015
- JGES guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resectionDigestive Endoscopy, 2015
- Cancer Risk After Resection of Polypoid Dysplasia in Patients With Longstanding Ulcerative Colitis: A Meta-analysisClinical Gastroenterology and Hepatology, 2014
- Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort StudiesClinical Gastroenterology and Hepatology, 2012
- Increased Risk of Intestinal Cancer in Crohn's Disease: A Meta-Analysis of Population-Based Cohort StudiesAmerican Journal of Gastroenterology, 2005
- The risk of colorectal cancer in ulcerative colitis: a meta-analysisGut, 2001